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ABSTRACT 
Techniques for targeted genetic disruption in 
Plasmodium, the causative agent of malaria, are 
currently intractable for those genes that are essen-
tial for blood stage development. The ability to use 
RNA interference (RNAi) to silence gene expression 
would provide a powerful means to gain valuable 
insight into the pathogenic blood stages but its 
functionality in Plasmodium remains controversial. 
Here we have used various RNA-based gene silenc-
ing approaches to test the utility of RNAi in malaria 
parasites and have undertaken an extensive com-
parative genomics search using profile hidden 
Markov models to clarify whether RNAi machinery 
exists in malaria. These investigative approaches 
revealed that Plasmodium lacks the enzymology 
required for RNAi-based ablation of gene expres-
sion and indeed no experimental evidence for RNAi 
was observed. In its absence, the most likely expla-
nations for previously reported RNAi-mediated 
knockdown are either the general toxicity of intro-
duced RNA (with global down-regulation of gene 
expression) or a specific antisense effect mechanis-
tically distinct from RNAi, which will need system-
atic analysis if it is to be of use as a molecular 
genetic tool for malaria parasites. 
INTRODUCTION 
RNA interference (RNAi) is an evolutionarily conserved 
mechanism found across a range of eukaryotes, where it 
plays a key role in post-transcriptional gene regulation 
and in the protection of genomes from intrinsic and extrin-
sic threats (1). With its exquisite specificity for the target 
gene as well as its potent and reversible action, RNAi 
technology has now become a standard technique in the 
molecular toolbox for reverse genetic experimentation 
in many systems, providing a quick and easy means to 
gain valuable insight into gene function, in particular 
those that are essential to cell viability. The process of 
RNAi is triggered by the recognition of double-stranded 
RNA (dsRNA), which is then processed into 21-25 
nucleotide sequences by Dicer, a cytoplasmic dsRNA-
specific RNaseIII endonuclease (2-5). The processed 
short interfering RNAs (siRNAs) that are generated asso-
ciate with an RNA-induced silencing complex (RISC) and 
unwind in a strand-specific manner (3). The resulting 
siRNAs are then able to target homologous mRNA for 
degradation in combination with the RNaseH enzyme 
Argonaute (Slicer) (6). The first stage of dsRNA proces-
sing can be bypassed by introducing sequence-specific 
siRNAs directly into cells. 
The blood stage malaria parasite is responsible for all 
of the debilitating clinical symptoms of the malaria disease 
and is therefore a central focus of research to find new 
therapeutic approaches (7). The malaria parasite is hap-
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loid for most of its life cycle, including the pathogenic 
asexual forms that proliferate in the blood. Current tech-
nologies for the genetic manipulation of Plasmodium are 
limited to this stage of parasite development, through the 
introduction of exogenous DNA containing drug-resistant 
markers and subsequent drug selection. It is self-evident, 
therefore, that a malaria gene encoding a product essential 
to blood stage asexual growth would be resistant to 
permanent genetic disruption. Although two methods 
have recently been developed that allow inducible expres-
sion in the most virulent human malaria parasite, 
Plasmodium Jalciparum (8,9), neither has successfully 
been utilized to create full inducible gene knockouts, 
most likely because of an inherent leakiness in both sys-
tems. Given the immense burden of malaria disease and 
the need for new drug targets, in particular those essential 
for development of the pathogenic blood stages, the ability 
to utilize a gene silencing approach such as RNAi would 
clearly be extremely beneficial. 
To date there have been several reports describing 
the use of RNAi for gene silencing in the blood stages 
of Plasmodium. These have involved introducing either 
long dsRNAs by direct electroporation into erythrocytes 
infected with P. Jalciparum (10--12) or the addition of 
siRNAs into the culture medium (13-16). In addition, 
siRNAs have been injected into mice infected with the 
rodent malaria parasite P. berghei (17). While these studies 
suggest that RNAi may be functional in malaria parasites, 
targeting of specific genes in all of these cases resulted in 
parasite death or significant growth defects. Since these 
processes most probably lead to a global down-regulation 
of expression of many genes, it will be difficult to demon-
strate the specific effect of the siRNA on expression of the 
target gene. For example, based on RNAi targeting of 
fa1cipain-l, a protease involved in the degradation path-
way for hemoglobin, it has been concluded that this pro-
tein is essential for P.falciparum blood-stage growth (14). 
However, this finding is at odds with the demonstration 
that disruption of this gene by standard knockout tech-
nologies has no apparent effect on blood stage develop-
ment (18). These observations question the specificity of 
gene targeting by siRNA's in Plasmodium. Indeed, unpub-
lished observations [cited by Blackman (19)] have sug-
gested that the introduction of long dsRNA or siRNAs 
directed against P. Jalciparum SUB-lor AMA-I did not 
lead to silencing of expression of the target genes. In addi-
tion, several studies have been unable to detect even dis-
tant homologues of either Dicer or Argonaute in the 
P. Jalciparum or P. berghei genomes (19-24) and two 
recent studies failed to isolate P. Jalciparum micro-RNAs 
(miRNAs), a class of endogenous regulatory short RNAs 
that also act through the RNAi pathway (25,26). 
However, the failure to detect in Plasmodium homologues 
of the genes involved in RNAi silencing found in other 
organisms might be due to the unusually high AT-content 
of Plasmodium genomes which has notoriously caused 
difficulties in identifying genes where there is poor conser-
vation. Therefore, the question of the presence of a highly 
divergent RNAi machinery in Plasmodium remains open. 
In an attempt to clarify whether RNAi is functional 
in Plasmodium, we have taken a variety of RNA-based 
strategies to target genes in P. Jalciparum and P. berghei 
that are non-essential to growth or development and 
analysed their expression. Additionally, we have under-
taken an extensive comparative analysis of available 
Apicomplexan and other protozoan genomes using sensi-
tive profile hidden Markov models of domains (rather 
than simply sequence homology or PSIjRPS-BLAST 
based searches) in an attempt to determine whether 
a primitive RNAi machinery exists in Apicomplexa. 
Together our data argue that RNAi is absent in malaria 
parasites and therefore it is unlikely that RNAi-based gene 
silencing will prove to be a reliable approach to unravel 
the function of malaria proteins. 
MATERIALS AND METHODS 
Generation of RNA interference constructs 
Two dsRNA hairpin structures were created-one based 
on KAHRP for testing RNAi in P. Jalciparum and the 
other based on CTRP for testing RNAi in P. berghei. 
For the KAH RP hairpin structure, 407 bp of the 
KAHRP gene (PFBOI00c) was PCR-amplified from 3D7 
genomic DNA using the oligonucleotides RNAiF and 
RNAiR or RNAiF(HjX) and RNAiR (Figure I A, 
Supplementary Data SI for oligonucleotide sequences). 
A luciferase stuffer region of 437bp was amplified from 
pDlucAD (27) using the oligonucleotides lucF and lucR. 
The PCR products were cloned sequentially into pHH I 
(28) to create plasmid pHHjKRNAi (Figure lA). For 
the CTRP hairpin structure, a 2.7 kb promoter fragment 
upstream of the translation initiation codon of CTRP 
(PB000233.00.0) was amplified from genomic DNA of 
the P. berghei line cl5cyll (HP) with oligonucleotides 
CpXbaI and CpCla!. For the CTRP inverted repeat, 
680 bp of the CTRP ORF wa~ PCR amplified using 
oligonucleotides 764 and 770 or 769 and 770. A 270 bp 
stuffer fragment separating the inverted CTRP fragments 
was amplified from Anopheles gambiae genomic DNA 
using the oligonucleotides 749 and 750. The P28 3'UTR 
was amplified using oligonucleotides 753 and 754. These 
fragments were all cloned sequentially to yield the final 
plasmid construct pCTRPdsRNA (Figure 2A). 
To assess whether antisense mRNA can silence gene 
expression in P. Jalciparum, the constructs pHHjlucS 
and pHHjlucAS were constructed (Figure 3A). The con-
structs pHHjlucS and pCC4jlucS are based on pHHl or 
pCC4, respectively and harbour the luciferase gene in the 
sense orientation relative to the hsp86 5' untranslated 
region, whereas pHHjlucAS harbours the luciferase gene 
in the antisense orientation. The vector pHHjCA T har-
bours the chloramphenicol acetyl transferase gene in place 
of the luciferase gene (29). 
P. Jalciparum culturing and transfection 
Parasite cultures of P. Jalciparum 3D7 and DIO were 
maintained and synchronized as per standard procedures. 
Stable transfections with pHHjKRNAi and transient tras-
fections with various combinations of sense and antisense 
constructs are described in the Supplementary Data. 
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Figure 1. KAHRP dsRNA is transcribed in P. Jalciparum but does not silence endogenous KAHRP. (A) Schematic of the two exon structure of the 
endogenous KAHRP locus and the construct pHH/KRNAi, created to generate dsRNA for silencing endogenous KAHRP. Large arrows above 
pHH/KRNAi indicate direction of transcription and position of oligonucleotides used for PCR or RT-PCR are indicated by small arrowheads. The 
human DHFR (hDHFR) selectable marker cassette is under the transcriptional control of the CAM 5' and HRP2 3' untranslated regions. Promoter 
regions are symbolized by right-angled arrows and the 3' untranslated regions necessary for gene expression by a circle. (B) Transgenic 3D7/KRNAi 
parasites transcribe dsRNA. Total RNA was isolated from asynchronized parental (3D7) or transgenic (3D7/KRNAi) parasites and cDNA was then 
generated using oligo d(T) or a luciferase specific primer (lucR). RT -PCRs were performed with the oligonucleotides either in the presence (+) or 
absence (-) of reverse transcriptase. As controls, genomic DNA (gDNA) isolated from 3D7 or pHH/KRNAi DNA was also used. (C) Northern blot 
analysis of RNA isolated from 3D7 parental or 3D7/KRNAi transgenic parasites across the asexual life cycle (Expl) or during the stage of parasite 
development when KAHRP expression is at its peak (Exp2 and Exp3) using probes directed against luciferase (LUC), PFl4_0344 or KAHRP 
confirms the KAHRP hairpin· structure is transcribed yet is not capable of destabilizing KAHRP mRNA. The percentage of relative KAHRP 
expression was calculated by determining the level of KAHRP transcripts relative to that of PFl4_0344 for both 3D7/KRNAi and 3D7, with the 
latter being normalized to 100%. ER, early ring-stages; R, rings; LR, !ate rings; ET, early trophozoites; LT, late trophozoites. 
P. berghei transfection, parasite culture and cloning 
Asexual stage P. berghei parasites (HP line) were trans-
fected with pCTRPdsRNA according to lanse et at. 
(30). Parasites resistant to pyrimethamine selection were 
cloned by limiting dilution. Three parasite clones 
(299cll, 2 and 3) were positive for integration into the 
C or D SSU (Supplementary Data); clone 2 was chosen 
for further experiments. 
siRNA design and introduction into culture 
Four independent siRNAs (to avert possible non-
functionality of any single RNAi) were designed for 
three genes that have previously been knocked out in 
3D7: KAHRP (31), PfRh2a (32) and EEAl75 (33) (see 
Supplementary Data S2 for sequences). The siRNAs 
were used at 50-200 Jlgjml final concentration as described 
previously (I5,16). 0.5 ml of culture at ring-stages follow-
ing sorbitol treatment ("-'8-12 h) was incubated with each 
siRNAs in a 24-well culture plate in serum free medium 
for 30 min with intermittent mixing. Subsequently, 
Albumax™ (Gibco BRL) was added at a final concentra-
tion of 10% and parasites were maintained for 24 h until 
late trophozoite or schizogony. For immunoblot analysis 
parasites were harvested at late schizogony ("-'40 h post 
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Figure 2. CTRP dsRNA does not silence endogenous CTRP during P. berghei ookinete deVelopment. (A) Schematic representation of the endo-
genous CTRP locus and the construct pCTRPdsRNA used to generate dsRNA for silencing endogenous CTRP. Large arrows above pCTRPdsRNA 
indicate direction of transcription and position of oligonucleotides used for PCR or RT-PCR are indicated by small arrowheads. The T. gondii 
DHFR (TgDHFR/TS) selectable marker cassette is under the transcriptional control of the P. berghei DHFR 5f and DHFR 3f untranslated regions. 
Promoter regions are symbolized by right-angled arrows and the 3f untranslated regions necessary for gene expression by a circle. (8) Transgenic 
P. berghei 299cl2 transcribe dsRNA. Total RNA was isolated from an in vitro ookinete culture of HP parental and transgenic 299cl2 lines 16-h post-
induction and eDNA was then generated using oligo d(T). RT -PCRs were performed with the oligonucleotides shown, either in the presence (+ ) or 
absence (-) of reverse transcriptase. As a control pCTRP/dsRNA DNA was also used. (C) Comparison of steady state levels of CTRP and WARP 
RNA during ookinete development (4-20-h post-induction) by Northern blot analysis. Two independent 299cl2 RNA samples are shown. (D) Ratios 
of CTRP versus WARP RNA levels in parental HP (two samples) and 299cl2 (three samples). None of the differences are significant (unpaired t-test). 
invasion when RfRH2a, EBA175, MTRAP and GAP50 
are maximally expressed) or trophozoites (~20-24 h when 
KAHRP is maximally expressed), lysed with saponin and 
resuspended in reducing buffer. Immunoblots were probed 
with specific antibodies against each target protein 
[KAHRP (31), PfRh2a (32) and EBA175 (33), MTRAP 
or GAP50 (34)]. A portion of each parasite culture was 
retained and allowed to reinvade new erythrocytes. 
Percentage invasion relative to untreated controls was 
measured as previously described (35). 
RESULTS 
Stable expression of a dsRNA hairpin does not effectively 
silence expression of P. Jalciparum and P. berghei genes 
To determine whether transcription of a gene could be 
silenced using RNAi in p, Jalciparum, a double-stranded 
hairpin construct was made which was designed to specif-
ically target the gene KAHRP (PFBOlOOc), in a manner 
similar to that described for Trypanosoma brucei, a proto-
zan pathogen in which RNAi has been validated (36). 
KAHRP is known to be non-essential to the blood 
stages as knockout parasites are viable, although they 
do have a distinct phenotype (31), The construct pHH/ 
KRNAi contains two opposing KAHRP fragments sepa-
rated by a non-P.jalciparum 'stuffer' region derIved from 
a portion of the firefly luciferase gene with expression 
driven by the P. Jalciparum HSP86 promoter region. 
This construct was transfected into the 3D7 parasite line 
pre-selected for the presence of knobs and hence expres-
sion of KAHRP, with stable transfectants termed 
3D7/KRNAi. Transcription of the dsRNA transgene in 
P. Jalciparum was investigated using both RT-:-PCR and 
Northern blot analysis (see Supplementary Data for meth-
ods), Endogenous KAHRP was successfully amplified 
using oligonucleotides KF2 and KF3 from both 3D7 and 
3D7/KRNAi whilst no product could be detected with 
cDNA made from a KAHRP knockout line (37) 
confirming the specificity of the reaction (Figure IB and 
data not shown). dsRNA-specific cDNA amplification 
was, however, only observed in parasites transfected 
with pHH/KRNAi, indicating that the hairpin structure 
is indeed transcribed in 3D7/KRNAi (Figure IB). This 
was also confirmed by Northern blot analysis of RNA 
isolated from the two lines and probed with the LUC 
stuffer region (Figure IC, top panel). As expected, bands 
corresponding to LUC transcript were detected in the 
transfected parasite line 3D7/KRNAi, but not in the 
wild-type 3D7line. 
Having established stable expression of KAHRP 
dsRNA, we next sought to determine whether transcrip-
tion of the transgene resulted in modulation of the 
amount of KAHRP transcripts. Northern blots of RNA 
isolated from 3D7 and 3D7/KRNAi that were hybridized 
with a probe which recognizes only endogenous KAHRP 
and not the dsRNA transcript revealed that the pres-
ence of the hairpin structure did not affect the levels of 
KAHRP expression (Figure IC). To safeguard against 
asynchrony between the two lines, parasites were har-
vested at different time points during their life cycle and 
the transcription levels of KAHRP relative to PF14_0344 
(an unrelated gene chosen as a control) in the 3D7/ 
KRNAi line were normalized to levels obtained for 
3D7. Accounting for possible asynchrony, and despite 
the presence of highly abundant dsRNA transcripts pres-
ent in the 3D7/KRNAi line (Figure IC, ExpI), no gene 
silencing effect was observed. Indeed, by the latter time 
points there was actually more KAHRP expression rela-
tive to PF14_0344 in the 3D7/KRNAi line than in the 
3D7 wild-type line with overall cumulative transcrip-
tional expression for KAHRP being 86.1 % in transfectant 
versus wild-type. Two repeat experiments (Exp2 and 
Exp3), this time at the late ring and early trophozoite 
stages when KAHRP expression is at its peak showed 
similar results. Together this data strongly suggests that 
the KAHRP dsRNA was unable to efficiently destabilize 
the amount of steady state endogenous KAHRP mRNA 
at least to any levels that could be used to analyse gene 
function. 
Similar results were obtained in our attempts with the 
rodent malaria parasite P. berghei. A plasmid construct 
containing a 680 bp inverted CTRP repeat separated by 
a stuffer fragment from A. gambiae was stably introduced 
into the CjD-SSU unit on chromosomes 5 and 6 of 
P. berghei (Figure 2A). The CTRP gene (PB000233.00.0) 
encodes a surface receptor essential to insect stage parasite 
development (motility), but is not expressed in blood stage 
parasites and should therefore be amenable to knockdown 
or knockout (38). Here, transcription of the dsRNA was 
placed under the control of the CTRP promoter, ensuring 
that its expression was transcribed at the same time as 
the target mRNA. Using three different oligonucleotide 
combinations it was confirmed that the dsRNA was tran-
scribed in transgenic 299cl2 insect stage ookinetes 
(Figure 2B, see Supplementary Data for methods). 
The ability of this dsRNA to specifically destabilize 
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endogenous CTRP mRNA in ookinetes was then investi-
gated by Northern analysis of parental P. berghei HP and 
transgenic 299cl2 parasites at 4, 8, ) 2, 16 and 20 h post-
induction (hpi) of sexual development using a CTRP 
probe that recognizes only endogenous mRNA and not 
the dsRNA (Figure 2C, see Supplementary Data for meth-
ods). As expected, transcription of CTRP in all cultures 
increased steadily and peaked at 16 hpi during ookinete 
development. When the ratio of expression was calculated 
relative to WARP (PB000020.03.0), an ookinete spe-
cific gene that has a similar temporal expression patterns 
to CTRP, it was revealed that any down-regulation 
of CTRP was not significant (Figure 2C and D). 
Furthermore, at 12 and 13 min post-induction exflagela-
tion centres were counted and the ookinete conversion 
rates calculated (data not shown). No differences in devel-
opment were observed between the parental and trans-
genic 229cl2 parasite lines indicating that there were no 
significant off-target effects as a result of the transgene 
expression. This adds further support to our data from 
P. Jalciparum that dsRNA is not effective at silencing 
gene expression in malaria parasites. 
Generation of antisense mRNA does not lead to gene 
silencing in P. Jalciparum 
In the absence of dsRNA-mediated silencing we next 
sought to determine whether silencing could be achieved 
using antisense mRNA. P.falciparum parasites were tran-
'siently co-transfected with a range of constructs that 
were designed to generate sense and/or antisense firefly 
luciferase (F-luc) mRNA (Figure 3A). These parasites 
were co-transfected with a construct containing the 
Renilla luciferase (R-luc) gene in order to normalize 
for the variation in transfection efficiency across differ-
ent transient transfection experiments by measuring 
R-luc activity. As can be observed from Figure 3B, 
F-luc activity could be detected in parasites transfected 
with either F-luc mRNA sense constructs, pHH/lucS or 
pCC4/1ucS alone, and in parasites co-transfected with 
both pHH/lucS and pHH/CA T. Furthermore, as 
expected, no F-luc activity could be detected in parasites 
transfected with either the antisense construct pHH/lucAS 
or with pHH/CAT alone. However, the co-transfection of 
antisense and sense F-luc mRNA constructs together 
(pHH/lucAS with either pHH/lucS or pCC4/lucS) did 
not lead to reduction in F-Iuc activity in two independent 
transfections (Figure 2B) or in a repeat experiment (data 
not shown). The inability of antisense mRNA from F-Iuc 
to silence luciferase expression from sense mRNA strongly 
suggests that antisense mRNA is not a general mechanism 
of gene silencing in malaria parasites. 
Introduction of exogenous siRNAs does not lead to gene 
silencing in P. Jalciparum 
In the absence of evidence that full length RNA constructs 
can mediate effective gene silencing in P. Jalciparum, we 
sought to determine whether we could bypass the need for 
RNA processing and use exogenously introduced siRNAs 
to disrupt gene expression. 3D7 parasites were incubated 
with independent siRNAs (to detect possible experimental 
6 Nucleic Acids Research, 2009 
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Figure 3, Expression of antisense mRNA fails to knock-down transient luciferase activity. (A) Schematic of two constructs, pHH/lucS and pHH/ 
lucAS, designed to generate sense or antisense luciferase mRNA in P. falciparum, respectively. The large arrow indicates the direction of transcrip-
tion. (B) Luciferase activity observed in parasite extracts transiently transfected with various plasmid combinations. The level of firefly luciferase was 
normalized to the level of R. reniformis luciferase to control for variation in transfection efficiency across experiments. The firefly luciferase activity 
observed in parasites transfected with pHH/lucS and pCC4/lucS were set at 100%, with all other luciferase activities observed in other transfected 
parasites containing pHH/lucS or pCC4/lucS expressed relative to these, respectively. No antisense/sense mediated knockdown of luciferase activity 
can be seen, irrespective of vector source for luciferase expression. 
variation among siRNAs) at at least two different concen-
trations (50, 100 or 200 IlgJml). The target genes included 
the non-essential genes KAHRP, PJRh2b (MAL13P1.176) 
and EBA-175 (PF07_0128) as well as two putatively essen-
tial genes, MTRAP (PFlO_0281) and GAP50 (PFI0880c) 
(34). As a negative control a scrambled siRNA with no 
homology. to the p, Jalciparum 3D7 genome was used. 
These experiments were performed following protocols 
used in those studies that have reported successful 
siRNA-mediated gene silencing in Plasmodium (13-16), 
After co-culture of blood stage parasites with the 
siRNA, parasites were harvested and the targeted protein 
levels investigated by immunoblot. Although the protein 
levels of the targeted genes did vary relative to the levels of 
the PfAldolase (PFI4_0425) protein [used as a loading 
control (34)], no consistent or siRNA-concentration 
dependent reduction in protein expression was observed 
for any protein targeted by the siRNA (Figure 4). 
Furthermore, no reduction in growth rate of the blood 
stages was seen following the siRNA treatment, with re-
invasion levels remaining consistent across all treatments 
(data not shown). These results strongly suggest that 
delivery of specific siRNAs to blood stages through the 
culture medium did not lead to specific gene silencing in 
P. Jalciparum. 
Comparative genomics suggests malaria parasites lack the 
core RNAi machinery components Argonaute and Dicer 
Previous studies have noted that the RNAi machinery is 
absent in P. Jalciparum (19-24), an observation that fits 
with our inability to find experimental evidence for RNAi 
in both P. Jalciparum or P. berghei. To address the possi-
bility that a primitive RNAi machinery might be present, 
that is highly divergent from-but structurally related 
to-that of other eukaryotes, we performed a sensitive 
comparative search of protein sequences from 18 eukary-
otic species, including two Plasmodium species and three 
other apicomplexan and four kinetoplastid protozoan 
parasites, for key domains involved in RNAi using profile 
hidden Markov models (HMMs) (see Supplementary 
Data for methods). Also included in the cohort of ana-
lysed genomes were those of species that are known to 
either perform RNAi (positive controls) or not (negative 
controls). Domain profile HMMs used included RNase3, 
double-stranded RNA binding motifs (dsrm) and 
double-stranded RNA-binding domains (dsRBD) for 
Dicer orthologues and PAZ and Piwi domains for 
Argonaute orthologues (2). This method, which has been 
successfully used to detect Plasmodium proteins that. have 
low sequence similarity to non-malaria proteins (39), 
greatly improves the chances of finding divergent 
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Figure 4. Exogenous introduction of siRNAs fails to knock-down 
endogenous protein levels. Immunoblots for five genes targeted by 
siRNAs specific for four (MTRAP 3 only and scrambled negative con-
trol) distinct regions of genes known to be tractable (KAHRP, EBA175 
and PfRh2a) or intractable (MTRAP and GAP50) to conventional 
knockout. Despite incubation at concentrations up to 1O(}--200llg/ml 
no consistent reduction in protein level can be seen for any gene. 
homologues of Argonaute and other RNAi-re1ated pro-
teins. To further increase the chances· of finding such 
homologues in P. Jalciparum, a high E-value threshold 
was used in addition to post hoc analyses of the over-pre-
dicted sequences looking for domain co-occurrence and by 
performing reciprocal domain searches and phylogenetic 
analysis. Unlike simple homology searches, including the 
use of PSI-BLAST, this comparative approach provides 
stronger support for protein absence where domains and 
domain co-occurrences are not present across entire phy-
logenetic clades. Furthermore, the inclusion of positive 
and negative controls allows us to monitor sensitivity 
and specificity. The results of all domain predictions 
across the 18 species are shown in Supplementary Data 
S3; The results of PAZ and Piwi domain profile searches, 
using both a high E-value threshold (10) and moderately 
conservative threshold (0.001), are summarized in Table 1, 
which shows the number of proteins found that contain 
predicted Piwi or PAZ domains for each species as well as 
co-occurring predicted Piwi and PAZ domains (E-value 
::;10). While sensitive HMM searches with a high 
E-value threshold predict six putative Piwi and 46 putative 
PAZ domains in P. Jalciparum, more conservative 
searches found none (Table 1). Furthermore, looking for 
proteins containing both a PAZ and a Piwi domain using 
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Table 1. Number of putative proteins containing predicted Piwi or 
PAZ domains or both domains across diverse eukaryotic species 
Species 
Homo sapiens 
Drosophila melanogaster 
Caenorhabditis elegans 
S. cerevisiae 
S. pombe 
Trichomonas vaginalis 
Giardia intestinalis 
Dictyoslelium discoideum 
Enthamoeba histolyca 
T. brucei 
T. cruzi 
Leishmania major 
Leishmania braziliensis 
Toxoplasma gondii 
Cryptosporidium parvum 
T. annulata 
P. falciparum 
P. yoelli 
E-values" 
Piwi 
10 10-3 
16 11 
12 11 
39 35 
10 0 
5 I 
3 2 
10 I 
17 5 
12 3 
3 2 
2 1 
4 1 
6 1 
4 1 
24 0 
18 0 
6 0 
12 0 
PAZ PAZ + Piwib 
10 10-3 10 
15 12 10 
16 12 II 
39 33 31 
17 0 0 
12 I I 
5 0 2 
9 0 I 
52 5 6 
25 2 3 
6 0 I 
4 0 0 
5 0 0 
2 1 I 
4 1 e Ie 
38 0 0 
23 0 1 
46 0 0 
38 0 0 
"Domains were predicted using profile HMMs with sensitive (10) and 
conservative (l0-3) E-value thresholds. 
blndicates the number of proteins containing both a PAZ and a Piwi 
domain. 
"The PAZ domain of the TgAGO homolog is upstream of. the 
annotated A TG start codon. 
a high E-value cut-off (10), we again found none in 
P. Jalciparum. This was recapitulated with searches using 
the sister species P. yoelii. The absence of proteins with 
a PAZ or Piwi domain as defined by the criteria used in 
this study supports the idea that Plasmodium does not 
contain an Argonaute homologue, not even a highly diver-
gent one. As a control, the same search approach that we 
had applied to Plasmodium confirmed the absence of a 
true Argonaute in the yeast Saccharomyces cerevisiae, 
whilst demonstrating its presence in Schizosaccharomyces 
pombe; results that match the known utility of RNAi in 
these organisms (24). Similarly, T. brucei is known to be 
RNAi positive (20), whilst sister species T. cruzi and the 
related trypanosomatid L. major are unable to perform 
RNAi and our search strategy supported these observa-
tions, detecting Argonaute homologies only in T. brucei 
(Table 1) (40,41). Of note, we identified in the apicom-
plexan Theileria annulata a hypothetical protein, 
TA13085, which contains weak matches to both PAZ 
and Piwi domains suggesting it may have an active 
Argonaute. However, the position of TA13085 amongst 
low scoring apicomplexan domain predictions on the PAZ 
phylogenetic tree (Supplementary Data S4) may indicate 
that it is a false positive and its putative function as an 
Argonaute requires experimental verification. Consistent 
with the absence of putative Argonaute homologs 
in Plasmodium, no Dicer/Drosha-like proteins could 
be detected in Plasmodium when searching using domain 
profiles consisting of two RNase3 domains or an RNase3 
domain and a double stranded RNA binding domain 
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Table 2. Reciprocal profile HMM search of sequences containing best scoring Piwi domains found in P. Jalciparum 
Accession Piwi domain 
Location Score E-valuea 
PFlI_0352 12-236 -140.9 1.4 
PFLl370w 29-258 -140.9 1.4 
PFl1_0059 14-252 -146.9 3.5 
PFI1125c 10-255 -149.1 4.9 
PFI0_0245 456-672 -151.4 6.9 
PFLl545c 301-555 -153.7 9.7 
aE-values for Piwi were obtained using hmmsearch. 
bE-values of the best overlapping domains were obtained using hmmpfam. 
(either dsrm or dsRNA_bind), either individually (using a 
low E-value threshold) or in combination (using a high 
cut-off) (Supplementary Data S5). Searches in other spe-
cies were consistent with their known ability to undertake 
RNAi. 
As a final stringent test to rule out the presence of low 
homology domains, a phylogenetic analysis of PAZ and 
Piwi domains was undertaken (Supplementary Data S4 
and S6). Phylogenetic trees of all predictions (E-value 
<2) show that proteins containing high scoring Piwi and 
PAZ domains cluster into groups. Low-scoring domains 
are however interspersed throughout the tree and have 
consistently longer branch lengths. This suggests that 
low scoring hits are either highly divergent homologues 
or unrelated proteins. The latter conclusion is supported 
by the fact that the low scoring Piwi domains in 
these proteins typically do not co-occur with a PAZ 
domain, arguing that these proteins are not true 
Argonaute-like proteins. Indeed, as shown in Table 2, 
the best scoring domain that overlaps each low-scoring 
Piwi domain in P. Jalciparum (analogous to the 
Reciprocal Best Hits), has a highly significant match to 
an alternative domain which is a much better predictor 
of the protein's function. Taken together, the failure to 
detect proteins containing Argonaute- and Dicer-like 
domains using this sensitive comparative genomics 
approach strongly suggests that Argonaute-like and 
other RNAi-related proteins are absent in Plasmodium, 
supporting earlier studies. 
DISCUSSION 
Although several studies have reported the use of RNA 
interference mechanisms for silencing gene expression in 
malaria parasites, there is still little consensus about 
whether the genus Plasmodium has an active RNAi path-
way. Importantly, the concept has not been supported 
by a clear demonstration that the Plasmodium genome 
contains any of the conserved RNAi machinery (e.g. 
Argonaute, Dicer). Here we combined a novel bioinfor-
matics search of the Plasmodium genome with a variety of 
biological investigations to establish if RNAi is a valid 
investigational approach for protein function in 
Plasmodium with a sound theoretical basis. In previous 
studies that reported successful targeting of genes with 
Best overlapping domain 
Domain name Location Score E-valueb 
Thioredoxin 165-275 81.6 2.6 x 10-21 
Pkinase 15-298 246.8 4.7 x 10-71 
MFS_l 17-374 5.5 0.012 
adh_short 61-228 142.8 9.9 x 10-40 
SIS 507-636 119.1 5.1 x 10- 15 
Cpn60_TCPl 89-615 559.5 3.4 x 10-165 
RNAi, the effect of gene silencing was determined by mea-
suring only the general effects on growth and/or metabo-
lism of the treated parasites. In our studies we attempted 
to measure directly the effect of RNAi on expression of 
target genes with a clear predicted outcome if successful; 
non-essential genes (outcome: does-dependent reductions 
in transcript and protein levels and impaired functional-
ity), essential genes (outcome: dose-dependent parasite 
death) and transgene reporters (outcome: dose-dependent 
reduction in luminescence). Stable and abundant expres-
sion of dsRNA hairpins targeting transcripts in blood 
stages of P. Jalciparum and in ookinetes of P. berghei 
produced no significant effect on steady state levels of 
their target mRNA species, precluding this approach for 
the analysis of the function of these proteins. In order to 
compensate for the absence of an obvious functional 
orthologue of Dicer (see below) exogenously produced 
siRNAs were introduced into the P. Jalciparum blood 
stages using a similar approach to previous reports on 
siRNA silencing of Plasmodium genes (13-16). Again, by 
measuring the effect on expression of five different pro-
teins, some of which are associated with merozoite inva-
sion of erythrocytes, we did not find consistent and 
significant reduction in protein expression for any of the 
transcripts targeted and no reduction in merozoite inva-
sion where relevant. While we have no proof of the effi-
ciency of uptake of siRNAs by P. Jalciparum, the 
methodologies used to treat the parasites with siRNA 
were based on protocols that have previously been 
reported to give rise to successful siRNA-mediated gene' 
silencing in this and other species. It is possible that other 
means of transfection such as electroporation of parasites 
may be required to efficiently introduce siRNAs into the 
cytoplasm of P. Jalciparum. However, in P. berghei we 
used the highly efficient Amaxa method of electroporation 
(30) to introduce siRNAs that target reporter gene tran-
scripts [green fluorescent protein (GFP) and luciferase] 
that are expressed from integrated transgenes. Using a 
variety of electroporation conditions, we were .unable to 
detect significant reduction in the expression of GFP and 
luciferase in transfected blood stages in multiple indepen-
dent experiments (data not shown). Although we again 
have no proof of the efficiency of siRNA delivery into 
P. berghei by these electroporation conditions, these 
studies provide no indications that gene silencing by 
siRNA delivery could be a worthwhile tool to dissect 
protein function in Plasmodium. Lastly, antisense is 
an approach that has been proven to be successful in 
reducing mRNA levels in several other protozoan species 
(42-47), however, transient transfection of P. falciparum 
blood stages with plasmids that generated antisense tran-
scripts targeting a luciferase reporter gene did not reduce 
the expression of luciferase. 
Taken together, our studies do not support the observa-
tions of previous studies in which RNAi has been used to 
silence genes. In one study, smaller molecular weight RNA 
species were detected after introducing exogenous dsRNA 
in the blood stages of P. falciparum and the presence of 
these small RNAs interpreted as evidence of digestion 
of the mature full length mRNA target by Dicer (14). 
Our inability to achieve gene silencing with stably pro-
duced dsRNA at different life cycle stages of the parasite 
and the absence of proteins with Dicer domains in 
Plasmodium (see below) might suggest that the small 
RNAs simply reflect degradation of the introduced 
dsRNA. In previous studies of siRNA-gene silencing 
(l3-16), a general defect in growth and/or metabolism of 
the parasites has been reported. These defects might also 
be explained not as the result of specific gene targeting but 
as a result of non-specific inhibitory effects. For example, 
the very high concentrations of siRNAs used in these 
studies (over 100 Ilg/ml) may cause non-specific growth 
inhibition of P. falciparum and consequently a global 
down-regulation of gene expression. One suggestion is 
that observed RNA-mediated silencing effects in these 
studies could have been due to an antisense phenomenon 
(48), whereby the antisense transcripts annealed to the 
mRNA, preventing processes such as translation by 
ribosomes. Indeed, antisense transcripts have been exten-
sively detected in the transcriptomes of P. falciparum 
although their functional significance remains obscure 
(49-51). In our hands, however, we found no evidence 
for antisense mediated silencing of expression when we 
targeted the expression of the reporter protein luciferase 
with antisense mRNA. 
The lack of experimental evidence in our studies for the 
presence of an active RNAi machinery in Plasmodium is 
given credence by the current and previous failures to 
bioinformatically identify Dicer and Argonaute ortholo-
gues in P. falciparum and P. yoelli. PAZ and Piwi domains 
have been found in all functional Argonaute proteins iden-
tified to date (2), and while low scoring hits to these 
domains were observed in several P. falciparum proteins, 
the two domains were never found to co-occur within a 
single protein. Furthermore, all the putative Piwi domain 
sequences that were identified had a more significant 
match to an alternative domain in a reciprocal'search. 
Importantly, our bioinformatics analysis approach when 
applied to other organisms that employ RNAi were in 
keeping with those of previous studies (20,24). In general 
the lack of Dicer and Argonaute homologies holds true for 
all apicomplexan genomes examined. Besides the Theileria 
protein that was noted, there is one further anomaly: the 
T. gondii genome harbours a protein with a strong match 
to Argonaute, although the PAZ domain in T. gondii 
lies upstream of the putative start codon (52). This is 
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interesting from an evolutionary perspective as it may 
present evidence for the loss of the RNAi machinery in 
protozoans. 
In other organisms RNAi plays a key role in biologi-
cal processes such as the control of endogenous gene 
expression, the silencing of transposable elements and 
repetitive genes or as a defence against viral attack (53). 
The Plasmodium genome does not apparently possess ret-
rotransposons or viral pathogens, and thus there may be 
no selective advantage to the malaria parasite in either 
retaining (or gaining) an RNAi machinery (54). 
Furthermore, native miRNAs, which ar", produced by 
the cleavage of endogenous dsRNAs by Dicer to regulate 
gene expression by inhibiting protein translation have not 
been identified in P.falciparum infected red blood cells nor 
in purified parasites (25,26). 
In conclusion, our studies did not reveal any functional 
or bioinformatics evidence for RNAi activity in 
Plasmodium, indicating the absence of the RNAi machin-
ery and the inadvisability of the application of RNAi to 
investigate gene function in I?lasmodium. Although our 
findings also indicate that gene regulation via antisense 
inhibiting protein translation is non-functional in P. falci-
parum, the abundant native antisense transcripts found in 
this organism leave open the question that antisense 
regulation of gene activity may be gene-specific (55) and 
thus further exploration· of this technology in malaria 
parasites may be warranted. 
SUPPLEMENTARY DATA 
Supplementary Data are available at NAR Online. 
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